Genetics in Medicine, ISSN 1098-3600, 02/2016, Volume 18, Issue 2, pp. 180 - 188
Purpose: Phenotypic overlap exists among type III Bartter syndrome (BS), Gitelman syndrome (GS), and pseudo-BS/GS -(p-BS/GS), which are clinically difficult to...
Bartter syndrome | Gitelman syndrome | salt-losing tubulopathy | pseudo-Gitelman | pseudo-Bartter | CLCNKB | HYPOKALEMIC ALKALOSIS | MOLECULAR ANALYSIS | GLOMERULAR-FILTRATION-RATE | ANOREXIA-NERVOSA | CHLORIDE CHANNEL GENE | GENETICS & HEREDITY | COTRANSPORTER | DEAFNESS | MUTATIONS | Diagnosis, Differential | Gitelman Syndrome - physiopathology | Humans | Bartter Syndrome - diagnosis | Child, Preschool | Male | Laxatives - adverse effects | Sodium - urine | Bartter Syndrome - genetics | DNA Mutational Analysis | Adolescent | Chlorides - urine | Gitelman Syndrome - diagnosis | Adult | Female | Bartter Syndrome - physiopathology | Gitelman Syndrome - genetics
Bartter syndrome | Gitelman syndrome | salt-losing tubulopathy | pseudo-Gitelman | pseudo-Bartter | CLCNKB | HYPOKALEMIC ALKALOSIS | MOLECULAR ANALYSIS | GLOMERULAR-FILTRATION-RATE | ANOREXIA-NERVOSA | CHLORIDE CHANNEL GENE | GENETICS & HEREDITY | COTRANSPORTER | DEAFNESS | MUTATIONS | Diagnosis, Differential | Gitelman Syndrome - physiopathology | Humans | Bartter Syndrome - diagnosis | Child, Preschool | Male | Laxatives - adverse effects | Sodium - urine | Bartter Syndrome - genetics | DNA Mutational Analysis | Adolescent | Chlorides - urine | Gitelman Syndrome - diagnosis | Adult | Female | Bartter Syndrome - physiopathology | Gitelman Syndrome - genetics
Journal Article
Case report - Gitelman's syndrome, 12/2006
Gitelman's syndrome is primarily renal tubular hypokalemic metabolic alkalosis with hypocalciuria and magnesium deficiency, a benign disorder, inherited as...
Hypocalciuria, hypokalemia, Bartter's syndrome
Hypocalciuria, hypokalemia, Bartter's syndrome
Journal
Kidney International, ISSN 0085-2538, 01/2017, Volume 91, Issue 1, pp. 24 - 33
Gitelman syndrome (GS) is a rare, salt-losing tubulopathy characterized by hypokalemic metabolic alkalosis with hypomagnesemia and hypocalciuria. The disease...
hypokalemic metabolic alkalosis | hypomagnesemia | SLC12A3 | thiazide-sensitive sodium-chloride cotransporter | salt-losing tubulopathy | Hypokalemia/blood | Angiotensin-Converting Enzyme Inhibitors/therapeutic use | Diagnosis, Differential | Anti-Inflammatory Agents, Non-Steroidal/therapeutic use | Genetic Testing | Bartter Syndrome/blood | Chloride Channels/genetics | Potassium/administration & dosage | Humans | Consensus Development Conferences as Topic | Rare Diseases/genetics | Sodium Chloride, Dietary/therapeutic use | Gitelman Syndrome/complications | Phenotype | Solute Carrier Family 12, Member 3/genetics | Ultrasonography | Calcium/urine | Quality of Life | Magnesium/administration & dosage | Angiotensin Receptor Antagonists/therapeutic use | Mutation | Chondrocalcinosis/etiology | Dietary Supplements | Practice Guidelines as Topic | SERUM POTASSIUM | FOLLOW-UP | HYPOKALEMIC ALKALOSIS | THERAPEUTIC APPROACH | BARTTERS-SYNDROME | BLOOD-PRESSURE | NCC GENE | GLUCOSE-METABOLISM | UROLOGY & NEPHROLOGY | CHANNEL GENE | SODIUM-CHLORIDE COTRANSPORTER | Rare Diseases - genetics | Gitelman Syndrome - drug therapy | Hypokalemia - blood | Magnesium - administration & dosage | Bartter Syndrome - diagnosis | Chloride Channels - genetics | Bartter Syndrome - urine | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Bartter Syndrome - genetics | Solute Carrier Family 12, Member 3 - genetics | Bartter Syndrome - blood | Chondrocalcinosis - prevention & control | Sodium Chloride, Dietary - therapeutic use | Calcium - urine | Magnesium - therapeutic use | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Potassium - administration & dosage | Chondrocalcinosis - etiology | Potassium - therapeutic use | Gitelman Syndrome - complications | Gitelman Syndrome - diagnosis | Potassium - blood | Gitelman Syndrome - genetics | Angiotensin Receptor Antagonists - therapeutic use | Hypokalemia - genetics | Magnesium - blood
hypokalemic metabolic alkalosis | hypomagnesemia | SLC12A3 | thiazide-sensitive sodium-chloride cotransporter | salt-losing tubulopathy | Hypokalemia/blood | Angiotensin-Converting Enzyme Inhibitors/therapeutic use | Diagnosis, Differential | Anti-Inflammatory Agents, Non-Steroidal/therapeutic use | Genetic Testing | Bartter Syndrome/blood | Chloride Channels/genetics | Potassium/administration & dosage | Humans | Consensus Development Conferences as Topic | Rare Diseases/genetics | Sodium Chloride, Dietary/therapeutic use | Gitelman Syndrome/complications | Phenotype | Solute Carrier Family 12, Member 3/genetics | Ultrasonography | Calcium/urine | Quality of Life | Magnesium/administration & dosage | Angiotensin Receptor Antagonists/therapeutic use | Mutation | Chondrocalcinosis/etiology | Dietary Supplements | Practice Guidelines as Topic | SERUM POTASSIUM | FOLLOW-UP | HYPOKALEMIC ALKALOSIS | THERAPEUTIC APPROACH | BARTTERS-SYNDROME | BLOOD-PRESSURE | NCC GENE | GLUCOSE-METABOLISM | UROLOGY & NEPHROLOGY | CHANNEL GENE | SODIUM-CHLORIDE COTRANSPORTER | Rare Diseases - genetics | Gitelman Syndrome - drug therapy | Hypokalemia - blood | Magnesium - administration & dosage | Bartter Syndrome - diagnosis | Chloride Channels - genetics | Bartter Syndrome - urine | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Bartter Syndrome - genetics | Solute Carrier Family 12, Member 3 - genetics | Bartter Syndrome - blood | Chondrocalcinosis - prevention & control | Sodium Chloride, Dietary - therapeutic use | Calcium - urine | Magnesium - therapeutic use | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Potassium - administration & dosage | Chondrocalcinosis - etiology | Potassium - therapeutic use | Gitelman Syndrome - complications | Gitelman Syndrome - diagnosis | Potassium - blood | Gitelman Syndrome - genetics | Angiotensin Receptor Antagonists - therapeutic use | Hypokalemia - genetics | Magnesium - blood
Journal Article
Pediatric Clinics of North America, ISSN 0031-3955, 02/2019, Volume 66, Issue 1, pp. 121 - 134
Bartter and Gitelman syndromes are conditions characterized by renal salt-wasting. Clinical presentations range from severe antenatal disease to asymptomatic...
Failure to thrive | Polyuria | Gitelman syndrome (GS) | Bartter syndrome (BS) | Hypokalemic hypochloremic metabolic alkalosis | Salt-losing tubulopathy | MANAGEMENT | CHANNEL GENE CLCNKB | SENSORINEURAL DEAFNESS | HYPOCALCEMIA | TRANSPLANTATION | CALCIUM-SENSING RECEPTOR | GROWTH-HORMONE | PEDIATRICS | MUTATIONS | REABSORPTION | Diagnosis, Differential | Bartter Syndrome - therapy | Humans | Bartter Syndrome - diagnosis | Gitelman Syndrome - diagnosis | Gitelman Syndrome - therapy | Child
Failure to thrive | Polyuria | Gitelman syndrome (GS) | Bartter syndrome (BS) | Hypokalemic hypochloremic metabolic alkalosis | Salt-losing tubulopathy | MANAGEMENT | CHANNEL GENE CLCNKB | SENSORINEURAL DEAFNESS | HYPOCALCEMIA | TRANSPLANTATION | CALCIUM-SENSING RECEPTOR | GROWTH-HORMONE | PEDIATRICS | MUTATIONS | REABSORPTION | Diagnosis, Differential | Bartter Syndrome - therapy | Humans | Bartter Syndrome - diagnosis | Gitelman Syndrome - diagnosis | Gitelman Syndrome - therapy | Child
Journal Article
Proceedings of the National Academy of Sciences, ISSN 0027-8424, 10/2011, Volume 108, Issue 42, pp. 17538 - 17543
Na + -K + -2Cl − cotransporters (NKCCs), including NKCC1 and renal-specific NKCC2, and the Na + -Cl − cotransporter (NCC) play pivotal roles in the regulation...
Bartter syndrome | Hormone | Electrolytes | Knockout mice | Volume | NA-CL COTRANSPORTER | knockout mice | CATION-CHLORIDE COTRANSPORTERS | SMOOTH-MUSCLE TONE | MULTIDISCIPLINARY SCIENCES | RENAL-FUNCTION | NA-K-2CL COTRANSPORTER | HYPOKALEMIC ALKALOSIS | electrolytes | BLOOD-PRESSURE | GITELMAN-SYNDROME | hormone | volume | TARGETED DISRUPTION | MOLECULAR PATHOGENESIS | Bartter Syndrome - metabolism | Potassium - metabolism | Protein-Serine-Threonine Kinases - deficiency | Phosphorylation | Water-Electrolyte Balance - physiology | Protein-Serine-Threonine Kinases - genetics | Aorta - metabolism | Sodium - metabolism | Sodium-Potassium-Chloride Symporters - metabolism | Hypotension - genetics | Receptors, Drug - metabolism | Symporters - metabolism | Mice, Knockout | Solute Carrier Family 12, Member 1 | Animals | Hypotension - metabolism | Solute Carrier Family 12, Member 2 | Solute Carrier Family 12, Member 3 | Bartter Syndrome - genetics | Blood Pressure - physiology | Mice | Kidney Tubules - metabolism | Protein-Serine-Threonine Kinases - metabolism | Disease Models, Animal | Biological Sciences
Bartter syndrome | Hormone | Electrolytes | Knockout mice | Volume | NA-CL COTRANSPORTER | knockout mice | CATION-CHLORIDE COTRANSPORTERS | SMOOTH-MUSCLE TONE | MULTIDISCIPLINARY SCIENCES | RENAL-FUNCTION | NA-K-2CL COTRANSPORTER | HYPOKALEMIC ALKALOSIS | electrolytes | BLOOD-PRESSURE | GITELMAN-SYNDROME | hormone | volume | TARGETED DISRUPTION | MOLECULAR PATHOGENESIS | Bartter Syndrome - metabolism | Potassium - metabolism | Protein-Serine-Threonine Kinases - deficiency | Phosphorylation | Water-Electrolyte Balance - physiology | Protein-Serine-Threonine Kinases - genetics | Aorta - metabolism | Sodium - metabolism | Sodium-Potassium-Chloride Symporters - metabolism | Hypotension - genetics | Receptors, Drug - metabolism | Symporters - metabolism | Mice, Knockout | Solute Carrier Family 12, Member 1 | Animals | Hypotension - metabolism | Solute Carrier Family 12, Member 2 | Solute Carrier Family 12, Member 3 | Bartter Syndrome - genetics | Blood Pressure - physiology | Mice | Kidney Tubules - metabolism | Protein-Serine-Threonine Kinases - metabolism | Disease Models, Animal | Biological Sciences
Journal Article
Current Opinion in Nephrology and Hypertension, ISSN 1062-4821, 09/2003, Volume 12, Issue 5, pp. 527 - 532
PURPOSE OF REVIEWThis review describes recent advances in our understanding of the genetic heterogeneity, pathophysiology and treatment of Bartter syndrome, a...
Extracellular calcium ion-sensing receptor | Hypokalemic metabolic alkalosis | Thick ascending limb | Renal tubule | Inherited disorder | Barttin | ClC-K | Chloride ion channel | Sodium chloride | Kidney | GITELMAN | INNER-EAR | extracellular calcium ionsensing receptor | SENSORINEURAL DEAFNESS | CIC-K | thick ascending limb | renal tubule | MICE LACKING | chloride ion channel | kidney | CALCIUM-SENSING RECEPTOR | CHLORIDE CHANNEL GENE | inherited disorder | hypokalemic metabolic alkalosis | UROLOGY & NEPHROLOGY | PERIPHERAL VASCULAR DISEASE | MUTATIONS | K+ CHANNEL | barttin | ROMK | sodium chloride | POTASSIUM CHANNEL | Ion Channels - genetics | Bartter Syndrome - physiopathology | Bartter Syndrome - therapy | Bartter Syndrome - genetics | Humans
Extracellular calcium ion-sensing receptor | Hypokalemic metabolic alkalosis | Thick ascending limb | Renal tubule | Inherited disorder | Barttin | ClC-K | Chloride ion channel | Sodium chloride | Kidney | GITELMAN | INNER-EAR | extracellular calcium ionsensing receptor | SENSORINEURAL DEAFNESS | CIC-K | thick ascending limb | renal tubule | MICE LACKING | chloride ion channel | kidney | CALCIUM-SENSING RECEPTOR | CHLORIDE CHANNEL GENE | inherited disorder | hypokalemic metabolic alkalosis | UROLOGY & NEPHROLOGY | PERIPHERAL VASCULAR DISEASE | MUTATIONS | K+ CHANNEL | barttin | ROMK | sodium chloride | POTASSIUM CHANNEL | Ion Channels - genetics | Bartter Syndrome - physiopathology | Bartter Syndrome - therapy | Bartter Syndrome - genetics | Humans
Journal Article
MEDICINE, ISSN 0025-7974, 07/2019, Volume 98, Issue 28, p. e16408
Rationale: The Gitelman's syndrome (GS) is characterized by metabolic alkalosis, hypokalemia, hypomagnesemia, and hypocalciuria. However, the involvement of...
parathyroid hormone | MEDICINE, GENERAL & INTERNAL | HORMONE | hyperphosphatemia | DISEASE | hypomagnesemia | COTRANSPORTER GENE | Gitelman's syndrome | MUTATIONS | hypocalciuric hypocalcemia | BARTTERS-SYNDROME | Antacids - therapeutic use | Hyperphosphatemia - complications | Gitelman Syndrome - drug therapy | Administration, Oral | Magnesium Oxide - therapeutic use | Humans | Gitelman Syndrome - complications | Adult | Female | Hyperphosphatemia - drug therapy | Hyperphosphatemia - genetics | Gitelman Syndrome - genetics | Case studies | Usage | Genetic disorders | Magnesium oxide | Phosphorus imbalance | Kidney diseases | Drug therapy
parathyroid hormone | MEDICINE, GENERAL & INTERNAL | HORMONE | hyperphosphatemia | DISEASE | hypomagnesemia | COTRANSPORTER GENE | Gitelman's syndrome | MUTATIONS | hypocalciuric hypocalcemia | BARTTERS-SYNDROME | Antacids - therapeutic use | Hyperphosphatemia - complications | Gitelman Syndrome - drug therapy | Administration, Oral | Magnesium Oxide - therapeutic use | Humans | Gitelman Syndrome - complications | Adult | Female | Hyperphosphatemia - drug therapy | Hyperphosphatemia - genetics | Gitelman Syndrome - genetics | Case studies | Usage | Genetic disorders | Magnesium oxide | Phosphorus imbalance | Kidney diseases | Drug therapy
Journal Article
JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, ISSN 1022-386X, 03/2017, Volume 27, Issue 3, pp. S30 - S32
Gitelman syndrome (GS) is the most frequently inherited renal salt-wasting tubulointerstitial disease. It follows variable but usually asymptomatic benign...
Gitelman syndrome | Bartter syndrome | MEDICINE, GENERAL & INTERNAL | Magnesium | Potassium | Metabolic alkalosis | Young Adult | Male | Humans | Gitelman Syndrome - diagnosis
Gitelman syndrome | Bartter syndrome | MEDICINE, GENERAL & INTERNAL | Magnesium | Potassium | Metabolic alkalosis | Young Adult | Male | Humans | Gitelman Syndrome - diagnosis
Journal Article
Current Opinion in Nephrology and Hypertension, ISSN 1062-4821, 09/2017, Volume 26, Issue 5, pp. 419 - 425
PURPOSE OF REVIEWAntenatal Bartter syndrome (aBS) is a heterogenous disease resulting from defective ion transport in the thick ascending limb of the loop of...
prostaglandin E 2 | antenatal Bartter syndrome | acute recurrent polyhydramnios | tubuloglomerular feedback | melanoma-associated antigen D2 | PROTEIN | RETICULUM-ASSOCIATED DEGRADATION | PHENOTYPE | SALT-LOSING TUBULOPATHIES | UBIQUITIN LIGASES | prostaglandin E-2 | MACULA DENSA | COTRANSPORTER | UROLOGY & NEPHROLOGY | CYCLOOXYGENASE-2 EXPRESSION | PERIPHERAL VASCULAR DISEASE | NKCC2 | FOCAL SEGMENTAL GLOMERULOSCLEROSIS | Antigens, Neoplasm - genetics | Sodium Chloride Symporters - metabolism | Humans | Bartter Syndrome - complications | Male | Sodium-Potassium-Chloride Symporters - metabolism | Premature Birth - etiology | Fetal Diseases - genetics | Pregnancy | Fetal Diseases - physiopathology | Renal Reabsorption | Polyhydramnios - etiology | Bartter Syndrome - genetics | Adaptor Proteins, Signal Transducing - genetics | Female | Bartter Syndrome - physiopathology | Polyuria - etiology | Mutation | Sodium Chloride - metabolism
prostaglandin E 2 | antenatal Bartter syndrome | acute recurrent polyhydramnios | tubuloglomerular feedback | melanoma-associated antigen D2 | PROTEIN | RETICULUM-ASSOCIATED DEGRADATION | PHENOTYPE | SALT-LOSING TUBULOPATHIES | UBIQUITIN LIGASES | prostaglandin E-2 | MACULA DENSA | COTRANSPORTER | UROLOGY & NEPHROLOGY | CYCLOOXYGENASE-2 EXPRESSION | PERIPHERAL VASCULAR DISEASE | NKCC2 | FOCAL SEGMENTAL GLOMERULOSCLEROSIS | Antigens, Neoplasm - genetics | Sodium Chloride Symporters - metabolism | Humans | Bartter Syndrome - complications | Male | Sodium-Potassium-Chloride Symporters - metabolism | Premature Birth - etiology | Fetal Diseases - genetics | Pregnancy | Fetal Diseases - physiopathology | Renal Reabsorption | Polyhydramnios - etiology | Bartter Syndrome - genetics | Adaptor Proteins, Signal Transducing - genetics | Female | Bartter Syndrome - physiopathology | Polyuria - etiology | Mutation | Sodium Chloride - metabolism
Journal Article
10.
Full Text
Bartter- and Gitelman-like syndromes: salt-losing tubulopathies with loop or DCT defects
Pediatric Nephrology, ISSN 0931-041X, 10/2011, Volume 26, Issue 10, pp. 1789 - 1802
Salt-losing tubulopathies with secondary hyperaldosteronism (SLT) comprise a set of well-defined inherited tubular disorders. Two segments along the distal...
Bartter syndrome | Gitelman syndrome | Pediatrics | Prostaglandins | Treatment | Medicine & Public Health | Salt-losing tubulopathies | Classification | Secondary hyperaldosteronism | Differential diagnosis | HYPERPROSTAGLANDIN-E SYNDROME | SENSORINEURAL DEAFNESS | AUTOSOMAL-DOMINANT HYPOCALCEMIA | PRETERM INFANTS | CHLORIDE CHANNEL GENE | CALCIUM-SENSING RECEPTOR | TUBULAR HYPOKALEMIC DISORDERS | UROLOGY & NEPHROLOGY | PEDIATRICS | MUTATIONS | K+ CHANNEL | LONG-TERM TREATMENT | Gitelman Syndrome - pathology | Kidney Tubules, Distal - pathology | Bartter Syndrome - therapy | Prognosis | Kidney Diseases - pathology | Humans | Hyperaldosteronism - pathology | Kidney Diseases - diagnosis | Aldosterone - physiology | Bartter Syndrome - diagnosis | Hyperaldosteronism - complications | Loop of Henle - metabolism | Aldosterone - pharmacology | Loop of Henle - pathology | Nephrons - pathology | Bartter Syndrome - pathology | Gitelman Syndrome - diagnosis | Kidney Diseases - therapy | Adult | Female | Gitelman Syndrome - therapy | Salts - metabolism | Kidney Tubules - pathology | Educational Review
Bartter syndrome | Gitelman syndrome | Pediatrics | Prostaglandins | Treatment | Medicine & Public Health | Salt-losing tubulopathies | Classification | Secondary hyperaldosteronism | Differential diagnosis | HYPERPROSTAGLANDIN-E SYNDROME | SENSORINEURAL DEAFNESS | AUTOSOMAL-DOMINANT HYPOCALCEMIA | PRETERM INFANTS | CHLORIDE CHANNEL GENE | CALCIUM-SENSING RECEPTOR | TUBULAR HYPOKALEMIC DISORDERS | UROLOGY & NEPHROLOGY | PEDIATRICS | MUTATIONS | K+ CHANNEL | LONG-TERM TREATMENT | Gitelman Syndrome - pathology | Kidney Tubules, Distal - pathology | Bartter Syndrome - therapy | Prognosis | Kidney Diseases - pathology | Humans | Hyperaldosteronism - pathology | Kidney Diseases - diagnosis | Aldosterone - physiology | Bartter Syndrome - diagnosis | Hyperaldosteronism - complications | Loop of Henle - metabolism | Aldosterone - pharmacology | Loop of Henle - pathology | Nephrons - pathology | Bartter Syndrome - pathology | Gitelman Syndrome - diagnosis | Kidney Diseases - therapy | Adult | Female | Gitelman Syndrome - therapy | Salts - metabolism | Kidney Tubules - pathology | Educational Review
Journal Article
Hypertension, ISSN 0194-911X, 06/2009, Volume 53, Issue 6, pp. 893 - 897
NA-CL COTRANSPORTER | PHYSIOLOGY | BARTTERS | HYPOCALCIURIA | PERIPHERAL VASCULAR DISEASE | HYPOKALEMIC ALKALOSIS | MUTATIONS | PREVALENCE | BLOOD-PRESSURE | Severity of Illness Index | Genetic Predisposition to Disease | Gitelman Syndrome - drug therapy | Prognosis | Blood Chemical Analysis | Risk Assessment | Muscle Weakness - diagnosis | Humans | Male | Hypotension - diagnosis | Magnesium Deficiency - diagnosis | Kidney Function Tests | Magnesium - therapeutic use | Young Adult | Hypotension - drug therapy | Pedigree | Muscle Weakness - drug therapy | Potassium - therapeutic use | Gitelman Syndrome - diagnosis | Magnesium Deficiency - drug therapy | Adult | Female | Drug Therapy, Combination | Dietary Supplements
Journal Article
Current Opinion in Pediatrics, ISSN 1040-8703, 04/2017, Volume 29, Issue 2, pp. 179 - 186
Purpose of review The clinical presentations of Bartter's syndrome and Gitelman's syndrome will be reviewed including two most recently described hypokalemic...
diagnostic and therapeutic management | Gitelman's syndrome | Bartter's syndrome | clinical presentations | physiologic and pharmacologic classification | HYPERPARATHYROIDISM | COTRANSPORTER | PEDIATRICS | MUTATIONS | NKCC2 | HYPOKALEMIA
diagnostic and therapeutic management | Gitelman's syndrome | Bartter's syndrome | clinical presentations | physiologic and pharmacologic classification | HYPERPARATHYROIDISM | COTRANSPORTER | PEDIATRICS | MUTATIONS | NKCC2 | HYPOKALEMIA
Journal Article
The EMBO Journal, ISSN 0261-4189, 11/2008, Volume 27, Issue 21, pp. 2907 - 2917
textabstractHuman Bartter syndrome IV is an autosomal recessive disorder characterized by congenital deafness and severe renal salt and fluid loss. It is...
otoacoustic emission | potassium recycling | inner ear | anion transport | Sox10 | Potassium recycling | Anion transport | Otoacoustic emission | Inner ear | OUTER HAIR-CELLS | INNER-EAR | CHLORIDE CHANNELS | ALPHA-SUBUNIT | BIOCHEMISTRY & MOLECULAR BIOLOGY | SENSORINEURAL DEAFNESS | STRIA VASCULARIS | CELL BIOLOGY | TIGHT JUNCTIONS | DOMINANT DEAFNESS | K CHANNELS | BETA-SUBUNIT | Stria Vascularis - pathology | Hair Cells, Auditory - metabolism | Hair Cells, Auditory - pathology | Humans | Stria Vascularis - ultrastructure | Evoked Potentials - physiology | Vestibule, Labyrinth - metabolism | DNA-Binding Proteins - metabolism | Endolymph | Cochlea - metabolism | Gene Deletion | SOXE Transcription Factors | Integrases - metabolism | Membrane Proteins - metabolism | Bartter Syndrome - metabolism | High Mobility Group Proteins - metabolism | Mice, Inbred C57BL | Bartter Syndrome - complications | Cochlea - physiopathology | Vestibule, Labyrinth - physiopathology | Vestibule, Labyrinth - pathology | Mice, Knockout | Chloride Channels - metabolism | Transcription Factors - metabolism | Animals | Deafness - complications | Deafness - metabolism | Models, Biological | Cochlea - pathology | Mice | Proteins | Deafness | Genetic disorders | Mutation | Molecular biology | Genes
otoacoustic emission | potassium recycling | inner ear | anion transport | Sox10 | Potassium recycling | Anion transport | Otoacoustic emission | Inner ear | OUTER HAIR-CELLS | INNER-EAR | CHLORIDE CHANNELS | ALPHA-SUBUNIT | BIOCHEMISTRY & MOLECULAR BIOLOGY | SENSORINEURAL DEAFNESS | STRIA VASCULARIS | CELL BIOLOGY | TIGHT JUNCTIONS | DOMINANT DEAFNESS | K CHANNELS | BETA-SUBUNIT | Stria Vascularis - pathology | Hair Cells, Auditory - metabolism | Hair Cells, Auditory - pathology | Humans | Stria Vascularis - ultrastructure | Evoked Potentials - physiology | Vestibule, Labyrinth - metabolism | DNA-Binding Proteins - metabolism | Endolymph | Cochlea - metabolism | Gene Deletion | SOXE Transcription Factors | Integrases - metabolism | Membrane Proteins - metabolism | Bartter Syndrome - metabolism | High Mobility Group Proteins - metabolism | Mice, Inbred C57BL | Bartter Syndrome - complications | Cochlea - physiopathology | Vestibule, Labyrinth - physiopathology | Vestibule, Labyrinth - pathology | Mice, Knockout | Chloride Channels - metabolism | Transcription Factors - metabolism | Animals | Deafness - complications | Deafness - metabolism | Models, Biological | Cochlea - pathology | Mice | Proteins | Deafness | Genetic disorders | Mutation | Molecular biology | Genes
Journal Article
Journal of the American Society of Nephrology, ISSN 1046-6673, 11/2010, Volume 21, Issue 11, pp. 1868 - 1877
Polymorphisms in the gene encoding sterile 20/SPS1-related proline/alanine-rich kinase (SPAK) associate with hypertension susceptibility in humans SPAK...
NA-CL COTRANSPORTER | OSR1 | UROLOGY & NEPHROLOGY | NA-K-2CL COTRANSPORTER | HYPOKALEMIC ALKALOSIS | HYPERTENSION | NA+-K+-2CL(-) COTRANSPORTER | VASCULAR SMOOTH-MUSCLE | BLOOD-PRESSURE | BARTTERS-SYNDROME | WNK KINASES | Protein-Serine-Threonine Kinases - deficiency | Male | Sodium-Potassium-Chloride Symporters - metabolism | Vasoconstriction - physiology | Hypotension - physiopathology | Hydrochlorothiazide - pharmacology | Female | Blood Pressure - physiology | Aorta - physiopathology | Disease Models, Animal | Sodium Chloride Symporters - metabolism | Gitelman Syndrome - physiopathology | Diuretics - pharmacology | Aorta - drug effects | Mice, Inbred C57BL | Protein-Serine-Threonine Kinases - genetics | Mice, Transgenic | Vasoconstriction - drug effects | Mice, Knockout | Transcription Factors - metabolism | Animals | Hypotension - metabolism | Mice | Gitelman Syndrome - metabolism | Furosemide - pharmacology | Basic Research
NA-CL COTRANSPORTER | OSR1 | UROLOGY & NEPHROLOGY | NA-K-2CL COTRANSPORTER | HYPOKALEMIC ALKALOSIS | HYPERTENSION | NA+-K+-2CL(-) COTRANSPORTER | VASCULAR SMOOTH-MUSCLE | BLOOD-PRESSURE | BARTTERS-SYNDROME | WNK KINASES | Protein-Serine-Threonine Kinases - deficiency | Male | Sodium-Potassium-Chloride Symporters - metabolism | Vasoconstriction - physiology | Hypotension - physiopathology | Hydrochlorothiazide - pharmacology | Female | Blood Pressure - physiology | Aorta - physiopathology | Disease Models, Animal | Sodium Chloride Symporters - metabolism | Gitelman Syndrome - physiopathology | Diuretics - pharmacology | Aorta - drug effects | Mice, Inbred C57BL | Protein-Serine-Threonine Kinases - genetics | Mice, Transgenic | Vasoconstriction - drug effects | Mice, Knockout | Transcription Factors - metabolism | Animals | Hypotension - metabolism | Mice | Gitelman Syndrome - metabolism | Furosemide - pharmacology | Basic Research
Journal Article
Journal of the American Society of Nephrology, ISSN 1046-6673, 08/2017, Volume 28, Issue 8, pp. 2540 - 2552
Bartter syndrome type 3 is a clinically heterogeneous hereditary salt-losing tubulopathy caused by mutations of the chloride voltage-gated channel Kb gene...
KIDNEY-DISEASE | DISTAL NEPHRON | CHLORIDE CHANNEL GENE | CALCIUM-SENSING RECEPTOR | GROWTH-HORMONE | CLCNKB | UROLOGY & NEPHROLOGY | SALT-LOSING TUBULOPATHIES | HYPOKALEMIC ALKALOSIS | MUTATIONS | GITELMAN-SYNDROME | Genetic Association Studies | Humans | Bartter Syndrome - diagnosis | Child, Preschool | Infant | Male | Young Adult | Bartter Syndrome - genetics | Adolescent | Adult | Female | Retrospective Studies | Mutation | Child | Life Sciences | Bartter-s syndrome | human genetics | chronic kidney disease | Clinical Research | proteinuria
KIDNEY-DISEASE | DISTAL NEPHRON | CHLORIDE CHANNEL GENE | CALCIUM-SENSING RECEPTOR | GROWTH-HORMONE | CLCNKB | UROLOGY & NEPHROLOGY | SALT-LOSING TUBULOPATHIES | HYPOKALEMIC ALKALOSIS | MUTATIONS | GITELMAN-SYNDROME | Genetic Association Studies | Humans | Bartter Syndrome - diagnosis | Child, Preschool | Infant | Male | Young Adult | Bartter Syndrome - genetics | Adolescent | Adult | Female | Retrospective Studies | Mutation | Child | Life Sciences | Bartter-s syndrome | human genetics | chronic kidney disease | Clinical Research | proteinuria
Journal Article